secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mineralys Therapeutics, Inc. (MLYS)
CIK:        0001933414
Form:       8-K
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001933414-23-000076
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mineralys appoints Karydas and Sblendorio to board after Takahashi resignation
------------------------------------------------------------------------------

- Takeshi Takahashi resigned from board on Sept 12; no disagreement cited.
- Board expanded to 8 members; appointed Daphne Karydas (Class III) and Glenn Sblendorio (Class II) effective Sept 13.
- Karydas named audit committee chair; Sblendorio named compensation committee chair.
- Each new director received options to purchase 44,000 shares vesting monthly over 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933414/000193341423000076/0001933414-23-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933414/000193341423000076/mlys-20230912.htm
  HTML page:      https://secwatch.observer/filing/0001933414-23-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer